Therefore, we hypothesized that excessive RIG-I inflammasome activation and subsequent IL-1β secretion in response to RV infection in asthma, resulted in persistent, but less efficient RIG-I-mediated anti-RV response. The gene discussed is IL1B; the disease is asthma.